2. It may reduce reliance on high-dose opioids/benzodiazepines and, in some cases, postpone the need for palliative sedation therapy This retrospective single-centre chart review from a New Zealand ...

Abstract: Background and Aim: Continuous subcutaneous insulin infusion (CSII) with sensor-augmented pumps is widely used in the treatment of type 1 diabetes. Patterning of glucose profiles using ...

You may want to lose body fat but might not know exactly where fat is stored in your body. That’s when knowing the difference between subcutaneous fat and visceral fat can be handy. The main ...

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...

The final segment discusses operational and logistical impacts, including workflow efficiency, staff training, and reimbursement considerations for subcutaneous immunotherapy. This program examines ...

Malignant bowel obstruction is common in patients with abdominal or pelvic cancers, being most prevalent in ovarian cancer, colorectal cancer and gastric cancer.1 The management and outcomes vary ...

Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment. Joshua K. Sabari, MD, director of High Reliability Organization ...

MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

With biosimilar competition heading toward Keytruda, Merck & Co. last Tuesday launched a subcutaneous version of the flagship cancer medication that analysts believe will significantly offset a ...

The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s bestselling drug potential blockbuster revenue protection.